Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survival.
Baudo A, Piccinelli ML, Incesu RB, Morra S, Scheipner L, Barletta F, Tappero S, Garcia CC, Assad A, Tian Z, Acquati P, de Cobelli O, Longo N, Briganti A, Terrone C, Chun FKH, Tilki D, Ahyai S, Saad F, Shariat SF, Carmignani L, Karakiewicz PI. Baudo A, et al. Among authors: de cobelli o. Surg Oncol. 2024 Jun;54:102074. doi: 10.1016/j.suronc.2024.102074. Epub 2024 Apr 9. Surg Oncol. 2024. PMID: 38615387
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.
Ferro M, Bruzzese D, Perdonà S, Marino A, Mazzarella C, Perruolo G, D'Esposito V, Cosimato V, Buonerba C, Di Lorenzo G, Musi G, De Cobelli O, Chun FK, Terracciano D. Ferro M, et al. Among authors: de cobelli o. PLoS One. 2013 Jul 4;8(7):e67687. doi: 10.1371/journal.pone.0067687. Print 2013. PLoS One. 2013. PMID: 23861782 Free PMC article.
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
Brookman-May SD, May M, Shariat SF, Novara G, Zigeuner R, Cindolo L, De Cobelli O, De Nunzio C, Pahernik S, Wirth MP, Longo N, Simonato A, Serni S, Siracusano S, Volpe A, Morgia G, Bertini R, Dalpiaz O, Stief C, Ficarra V; Members of the CORONA-Project; Members of the SATURN-Project; Young Academic Urologists Renal Cancer Group. Brookman-May SD, et al. Among authors: de cobelli o, de nunzio c. BJU Int. 2013 Nov;112(7):909-16. doi: 10.1111/bju.12246. Epub 2013 Jul 25. BJU Int. 2013. PMID: 23890378
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
Wolff I, May M, Hoschke B, Zigeuner R, Cindolo L, Hutterer G, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin MD, Salzano L, Lotrecchiano G, Shariat SF, Hohenfellner M, Waidelich R, Stief C, Miller K, Pahernik S, Brookman-May S; Members of the CORONA Project and the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group. Wolff I, et al. Among authors: de cobelli o, de nunzio c. Eur J Surg Oncol. 2016 May;42(5):744-50. doi: 10.1016/j.ejso.2016.01.009. Epub 2016 Jan 22. Eur J Surg Oncol. 2016. PMID: 26899942
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Verze P, Battaglia M, Serretta V, Russo GI, Morgia G, Musi G, de Cobelli O, Mirone V, Shariat SF. Ferro M, et al. Among authors: de berardinis e, de cobelli o. Urol Int. 2018;101(1):7-15. doi: 10.1159/000490765. Epub 2018 Jul 4. Urol Int. 2018. PMID: 29975950
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
Vartolomei MD, Ferro M, Cantiello F, Lucarelli G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdona S, Verze P, La Rocca R, Borghesi M, Schiavina R, Brunocilla E, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Serretta V, Russo GI, Morgia G, Terracciano D, Musi G, de Cobelli O, Mirone V, Shariat SF. Vartolomei MD, et al. Among authors: de berardinis e, de cobelli o. Clin Genitourin Cancer. 2018 Dec;16(6):445-452. doi: 10.1016/j.clgc.2018.07.003. Epub 2018 Jul 6. Clin Genitourin Cancer. 2018. PMID: 30077463
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.
Mistretta FA, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat SF, de Cobelli O, Karakiewicz PI. Mistretta FA, et al. Among authors: de cobelli o. Cancer Epidemiol. 2019 Apr;59:135-142. doi: 10.1016/j.canep.2019.02.002. Epub 2019 Feb 13. Cancer Epidemiol. 2019. PMID: 30771698
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.
Cantiello F, Russo GI, Vartolomei MD, Farhan ARA, Terracciano D, Musi G, Lucarelli G, Di Stasi SM, Hurle R, Serretta V, Busetto GM, Scafuro C, Perdonà S, Borghesi M, Schiavina R, Cioffi A, De Berardinis E, Almeida GL, Bove P, Lima E, Ucciero G, Matei DV, Crisan N, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Mirone V, Shariat SF, Ferro M. Cantiello F, et al. Among authors: de berardinis e, de cobelli o. Eur Urol Oncol. 2018 Oct;1(5):403-410. doi: 10.1016/j.euo.2018.06.006. Epub 2018 Jul 13. Eur Urol Oncol. 2018. PMID: 31158079
406 results